The role of the nucleus accumbens OXR1 in cocaine-induced locomotor sensitization-Reference-Cited by-同舟云学术

The role of the nucleus accumbens OXR1 in cocaine-induced locomotor sensitization

Published:2020-02 Issue: Volume:379 Page:112365
ISSN:0166-4328
Container-title:Behavioural Brain Research
language:en
Short-container-title:Behavioural Brain Research

Author:

Yang Mingda,Ma Hui,Jia Meng,Li Yijing,Miao Degen,Cui Cailian,Wu Liuzhen

Funder

National Basic Research Program of China

Science Fund for Creative Research Groups from the National Natural Science Foundation

National Key R&D plan

Publisher

Elsevier BV

Subject

Behavioral Neuroscience

Reference45 articles.

1. Cocaine effects on dopaminergic transmission depend on a balance between Sigma-1 and Sigma-2 receptor expression;Aguinaga;Front. Mol. Neurosci.,2018

2. Brain white matter integrity in heroin addicts during methadone maintenance treatment is related to relapse propensity;Li;Brain Behav.,2016

3. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons;Ungless;Nature,2001

4. Animal models of (or for) aggression reward, addiction, and relapse: behavior and circuits;Golden;J. Neurosci.,2019

5. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration;Davidson;Neuropsychopharmacology,2002

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of the circRNA–miRNA–mRNA network for treating methamphetamine‐induced relapse and behavioral sensitization with cannabidiol;CNS Neuroscience & Therapeutics;2024-05

2. Use of drug purchase tasks in medications development research: orexin system regulation of cocaine and drug demand;Behavioural Pharmacology;2023-06-22

3. Choline-Sigma-1R as an Additional Mechanism for Potentiation of Orexin by Cocaine;International Journal of Molecular Sciences;2021-05-13

4. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse;Neuropharmacology;2021-02